Olestra and the FDA
- 29 August 1996
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 335 (9) , 668-670
- https://doi.org/10.1056/nejm199608293350913
Abstract
As participants in the Food Advisory Committee assembled by the Food and Drug Administration (FDA) to consider the petition for approval of Olestra submitted by Procter & Gamble, we have a view of the approval process and recommendation of the committee that differs from that presented by Dr. Blackburn (April 11 issue).1Keywords
This publication has 7 references indexed in Scilit:
- Olestra and the FDANew England Journal of Medicine, 1996
- Intake of Carotenoids and Retino in Relation to Risk of Prostate CancerJNCI Journal of the National Cancer Institute, 1995
- Sucrose polyester and plasma carotenoid concentrations in healthy subjectsThe American Journal of Clinical Nutrition, 1995
- Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study GroupPublished by American Medical Association (AMA) ,1994
- Oral Anticoagulant DrugsNew England Journal of Medicine, 1991
- Vitamin K status of free-living subjects consuming olestraThe American Journal of Clinical Nutrition, 1991
- The Effect of Nonabsorbable Lipids on the Intestinal Absorption of LipophilesDrug Metabolism Reviews, 1982